39 results
Page 2 of 2
S-3
EX-4.9
h4urgm5by516ji5goe
5 Aug 22
Shelf registration
5:08pm
S-3
EX-4.8
pyoo7m643slvm7vds9ym
5 Aug 22
Shelf registration
5:08pm
S-3
k3sxyguw ew
5 Aug 22
Shelf registration
5:08pm
S-3
EX-1.2
4gpkb jdtdvhvggu1
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
2yed3 1akcp
26 May 22
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
5:36pm
10-K
EX-10.11
v92ekzhlwxoa
29 Mar 22
Annual report
8:46am
10-K
hym7zf5gmdm
29 Mar 22
Annual report
8:46am
10-Q
4yjd37w6ob2vly
8 Sep 21
Quarterly report
8:37am
424B4
w6zvfl
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.10
zpcr1kthisyf85eg
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
ur5ey7m0v0h
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-1.1
j3r0xbn9 rd
16 Jul 21
IPO registration (amended)
6:07am
S-1
EX-10.10
0uj7nwr52gqvfy
25 Jun 21
IPO registration
5:28pm
S-1
u47h85s2 61y6z
25 Jun 21
IPO registration
5:28pm
DRS/A
qjfkasg9k7wxfqx
31 Mar 21
Draft registration statement (amended)
12:00am